Elevated PRDX1 expression is associated with poor prognosis and reduced NK cell infiltration, indicating that PRDX1 may serve as a key regulator of tumor immune evasion and represents a promising therapeutic target in HCC. This evidence concerns the gene PRDX1 and hepatocellular carcinoma.